Is a complete IMRN research report available?

No complete published report is available for Immuron Limited (IMRN) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Immuron Limited (IMRN)

NASDAQ: IMRN · USD

$1.11

+0.02 (+1.4%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first IMRN analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	7.7M
Revenue (ttm)	5M
Net income (ttm)	-3.1M
EPS (ttm)	-$0.01
Shares out	326.7M
Volume	21,507
Beta	0.50

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 5M
Net income (ttm): -3.1M
EPS (ttm): -$0.01
Market cap: 7.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All IMRN indicators

Market & fundamental data

Available fields

195

Groups with data

Currency

AUD

Showing 195 of 195 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001660046
Company name	Immuron Limited
Country	Australia
Country code	US
Cusip	45254U101
Employees	7
Employees Change	1%
Employees Change Percent	16.67
Enterprise value	$910,661
Exchange	NASDAQ
Financial currency	AUD
First seen	2026-05-09
Industry	Biotechnology
Isin	US45254U1016
Last refreshed	2026-07-31
Market cap	$7.7M
Market cap category	Nano-Cap
Price	$1.11
Price currency	USD
Rev Per Employee	712,477x
Sector	Healthcare
Sector PE	45.51
Sector PE Fwd	24.23
Sic	2834
Symbol	IMRN
Website	https://www.immuron.com.au

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-40.29%
EV Sales Forward	0.11x
EV/Sales	0.18x
FCF yield	-42.94%
P/B ratio	0.88x
P/S ratio	1.54x
PS Forward	0.9x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-63.91%
EBITDA Margin	-63.91%
Gross margin	63.69%
Gross Profit	$3.2M
Gross Profit Growth	7.89%
Gross Profit Growth Q	67.92%
Gross Profit Growth3 Y	67.77%
Gross Profit Growth5 Y	56.02%
Net Income	$-3.1M
Net Income Growth Years	1%
Pretax Margin	-62.14%
Profit Margin	-62.14%
Profit Per Employee	$-442,735
ROA	-21.93
Roa5y	-17.99
ROCE	-37.89
ROE	-39.68
Roe5y	-35.12
ROIC	-25.21

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-33.15%
Cagr3y	-17.82%
Cagr5y	-25.54%
EPS Growth Years	1
Revenue Growth	14.3x
Revenue Growth Q	4.76x
Revenue Growth Years	4x
Revenue Growth3 Y	88.41x
Revenue Growth5 Y	50.07x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.55
Assets	$10.1M
Cash	$6.7M
Current Assets	$10.5M
Current Liabilities	$1.3M
Debt	$136,015
Debt Equity	$0.02
Equity	$8.7M
Interest Coverage	-510
Liabilities	$1.4M
Long Term Assets	$-387,199
Long Term Liabilities	$71,289
Net Cash	$6.5M
Net Cash By Market Cap	$84.9
Net Cash Growth	-39.74%
Net Debt Equity	$-0.75
Tangible Book Value	$8.7M
Tangible Book Value Per Share	$0.03
WACC	6.97

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.04
Inventory Turnover	1.44
Net Working Capital	$2.1M
Quick ratio	6.75
Working Capital	$8.7M
Working Capital Turnover	$0.33

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-11.16%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-33.13%
200-day SMA	1.13
3Y total return	-44.5%
50-day SMA	1.16
50-day SMA vs 200-day SMA	50over200
5Y total return	-77.11%
All Time High	28.99
All Time High Change	-96.17%
All Time High Date	2020-06-09
All Time Low	0.68
All Time Low Change	64.08%
All Time Low Date	2025-12-30
ATR	0.11
Beta	0.5
Ch YTD	45.57
High	1.14
High52	2.39
High52 Date	2025-10-16
High52ch	-53.56%
Low	1.03
Low52	0.68
Low52 Date	2025-12-30
Low52ch	64.08%
Ma50ch	-4.39%
Price vs 200-day SMA	-1.51%
RSI	47.36
RSI Monthly	42.18
RSI Weekly	50.04
Sharpe ratio	-0.07x
Sortino ratio	-0.04
Total Return	-11.16%
Tr YTD	45.57
Tr1m	2.78%
Tr1w	-5.13%
Tr3m	37.38%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-3.2M
Operating margin	-64.08

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	319,584,779%
Float Percent	97.84%
Net Borrowing	-40,275.8
Shares Insiders	2.16%
Shares Institutions	45.13%
Shares Out	326,653,609
Shares Qo Q	17.43%
Shares Yo Y	11.16%
Short Float	0.02%
Short Ratio	1.47
Short Shares	0.02

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-3.5M
Adjusted OCF	-3,513,188.9
Average Volume	51,435.65x
Bv Per Share	0.03
CAPEX	$-3,338
Ch1m	2.78
Ch1w	-5.13
Ch1y	-33.13
Ch3m	37.38
Ch3y	-44.5
Ch5y	-77.11
Ch6m	21.76
Change	1.37%
Change From Open	2.78
Close	1.1
Days Gap	-1.37
Depreciation Amortization	36,207
Dollar Volume	23,872.8
Earnings Date	2026-02-25
Earnings Time	bmo
EBIT	$-3.4M
EBITDA	$-3.4M
EPS	$-0.01
F Score	2
FCF	$-3.3M
FCF EV Yield	-362.68x
FCF Per Share	$-0.01
Financing CF	4,641,177
Fiscal Year End	June
Founded	1,994
Investing CF	107,693
Is Primary Listing	0
Is Spac	No
Last Earnings Date	2026-02-25
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2025-09-25
Ma150	0.95
Ma150ch	17.26%
Ma20	1.17
Ma20ch	-5.13%
Net CF	1,506,757
Next Earnings Date	2026-09-24
Open	1.08
Optionable	No
Position In Range	72.73
Post Close	1.11
Postmarket Change Percent	0.45
Postmarket Price	$1.12
Ppne	149,685.7
Price Date	2026-07-30
Ptbv Ratio	0.88
Relative Volume	0.42x
Revenue	4,987,339x
SBC By Revenue	4.07x
Share Based Comp	202,937
Tr6m	21.76%
Volume	21,507
Z Score	-2.04

Immuron Limited (IMRN)

Coverage state: Market snapshot only — no published research

Generate the first IMRN analysis

Price

Financial snapshot

Fair-value bridge

Latest news · IMRN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All IMRN indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on IMRN

Frequently asked questions